Automated Low Volume Dispensing Trends

Article   Nov 01, 2016 | Source

 
Automated Low Volume Dispensing Trends
 
 
 

RELATED ARTICLES

Advancing Drug Discovery Through Academic–Industry Collaboration

Article

Genestack recently announced that they were joining the Milner Therapeutics Institute. In light of the announcement, we spoke to Prof. Tony Kouzarides, Director of the Milner Therapeutics Institute and Dr. Misha Kapushesky, Founder and CEO of Genestack, to learn more.

READ MORE

The Lab of the Future: Artificial Intelligence, Machine Learning, and Microfluidics

Article

Today’s laboratories look very different to ten years ago, but what about ten years from now? When it comes to laboratory evolution, great strides have been made over the past decade, and further technological advancements are sure to bring us even closer to a fully automated ‘intelligent lab of the future’.

READ MORE

Phenotypic Screening in Drug Discovery

Article

There is an ever-growing curiosity in the potential benefit of combining phenotypic and genomic data, in the quest to advance small-molecule drug discovery. Understanding the advantages and challenges of phenotypic screening will help enhance its value as a tool for identifying drug candidates.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE